Trial Outcomes & Findings for A Clinical Registry to Collect Patient Outcome Date for the BIOMET® Stimulator Systems (NCT NCT01750840)

NCT ID: NCT01750840

Last Updated: 2017-06-19

Results Overview

Bone healing was assessed on x-rays and/or CT scan.

Recruitment status

TERMINATED

Target enrollment

8 participants

Primary outcome timeframe

The time frame for healing determination was not pre-specified. Patients were evaluated at regular doctors' visits for up to 12 months. The physician determined the time point at which healing occurred for each patient at their regular visits.

Results posted on

2017-06-19

Participant Flow

Participant milestones

Participant milestones
Measure
Stimulation Group
All patients will receive either the Biomet EBI Bone Healing System, Biomet OrthoPak Non-invasive Bone Growth Stimulator System or Biomet SpinalPak Non-Invasive Spine Fusion Stimulator Systems.
Overall Study
STARTED
8
Overall Study
COMPLETED
4
Overall Study
NOT COMPLETED
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Stimulation Group
All patients will receive either the Biomet EBI Bone Healing System, Biomet OrthoPak Non-invasive Bone Growth Stimulator System or Biomet SpinalPak Non-Invasive Spine Fusion Stimulator Systems.
Overall Study
Lost to Follow-up
4

Baseline Characteristics

A Clinical Registry to Collect Patient Outcome Date for the BIOMET® Stimulator Systems

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Stimulation Group
n=8 Participants
All patients will receive either the Biomet EBI Bone Healing System, Biomet OrthoPak Non-invasive Bone Growth Stimulator System or Biomet SpinalPak Non-Invasive Spine Fusion Stimulator Systems.
Age, Categorical
<=18 years
2 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Age, Continuous
40 years
n=5 Participants
Sex: Female, Male
Female
4 Participants
n=5 Participants
Sex: Female, Male
Male
4 Participants
n=5 Participants
Region of Enrollment
United States
8 participants
n=5 Participants

PRIMARY outcome

Timeframe: The time frame for healing determination was not pre-specified. Patients were evaluated at regular doctors' visits for up to 12 months. The physician determined the time point at which healing occurred for each patient at their regular visits.

Population: All patients, with one nonunion fracture each, were treated with the Biomet EBI Bone Healing System. Four patients had final healing outcomes reported (two patients with a 5th metatarsal nonunion, one patient with a tibial nonunion and one patient with a fibula nonunion) and all healed in an average time of 2.5 months.

Bone healing was assessed on x-rays and/or CT scan.

Outcome measures

Outcome measures
Measure
Stimulation Group
n=4 Fractures
All patients will receive either the Biomet EBI Bone Healing System, Biomet OrthoPak Non-invasive Bone Growth Stimulator System or Biomet SpinalPak Non-Invasive Spine Fusion Stimulator Systems.
Radiographic Assessment of Healing
100 percentage of healed fractures

SECONDARY outcome

Timeframe: The quality of life assessment was to be completed at the regular doctor's visit at which the physician determined the patient to be healed. No quality of life data was collected.

Population: No quality of life data was collected for any of the patients enrolled in the study. As such, no analysis was performed on quality of life measures.

Quality of life was intended to be measured by 5 scoring systems that ask a range of questions about the patient's pain and function. No quality of life data was captured for any of the patients and as such no quality of life analysis was performed.

Outcome measures

Outcome data not reported

Adverse Events

Stimulation Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Manager of Research

Biomet

Phone: 973-299-9300

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place